Responsible Research with 1cP-AL-LAD blotters
1cP-AL-LAD was only released onto the market very recently, so use extra caution when conducting research with this chemical.
WARNING This product is not for human or veterinary use.
What is 1cP-AL-LAD?
1cP-AL-LAD is a novel lysergamide that was first synthesized in the Netherlands towards the end of 2020. It is closely related to other lysergamides such as 1cP-LSD, LSD and AL-LAD.
Little is known about 1cP-AL-LAD as it was synthesized so recently. It is assumed to be a pro-drug of AL-LAD, as the metabolism takes place on the same indole nitrogen as the scientifically well-documented metabolism of 1cP-LSD and 1P-LSD to LSD. The AL-LAD-specific N-allyl substructure is on the “ethylamine” nitrogen, an atom that is very distant and which should not have any influence on the enzymatic reaction, therefore steric hindrance is very unlikely.
Reported pharmacological effects are very similar to AL-LAD. That being said, as with any novel compound, a researcher shouldn’t assume anything. Data is desperately needed on this and it’s down to members of the research community to provide this information. If you have any experience with
Some of the most commonly reported effects are:
Bodily control enhancement
Spontaneous physical sensations
Increased music appreciation
Pattern recognition enhancement
Visual acuity enhancement
Drifting (melting, breathing, morphing and flowing)
Depth perception distortions
Symmetrical texture repetition
It is illegal to buy 1cP-AL-LAD in:
- United Kingdom
This list is not exhaustive, so do your own research into the legal status in your country before ordering!
All products are strictly for research purposes only and not for human consumption.
Store in a cool, dry place away from sunlight. Lysergamides and Tryptamines should be kept below 20’c where possible